Alfons A den Broeder

11.5k citations

225 papers · 5.0k indexed · h-index 39

Rheumatology top 0.1%
Immunology top 2%
Hematology top 1%
Surgery top 5%
Genetics top 2%

Co-authors: F.H.J. van den Hoogen Jaap Fransen Piet L. C. M. van Riel C.H.M. van den Ende Bart J. F. van den Bemt Aatke van der Maas Wietske Kievit Călin D. Popa
Topics: Rheumatoid Arthritis Research and Therapies (143 papers)Autoimmune and Inflammatory Disorders Research (44 papers)Systemic Lupus Erythematosus Research (42 papers)
Cited by: Rheumatology Hematology Immunology
Journals: Annals of Internal Medicine PLoS ONE Scientific Reports
Partner nations: Netherlands United States United Kingdom

In The Last Decade

Alfons A den Broeder

211 papers receiving 4.9k citations

Peers

Countries citing papers authored by Alfons A den Broeder

Since Specialization

Citations

This map shows the geographic impact of Alfons A den Broeder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alfons A den Broeder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alfons A den Broeder more than expected).

Fields of papers citing papers by Alfons A den Broeder

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alfons A den Broeder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alfons A den Broeder. The network helps show where Alfons A den Broeder may publish in the future.

Co-authorship network of co-authors of Alfons A den Broeder

This figure shows the co-authorship network connecting the top 25 collaborators of Alfons A den Broeder. A scholar is included among the top collaborators of Alfons A den Broeder based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alfons A den Broeder. Alfons A den Broeder is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Cycle versus swap strategy after TNFi discontinuation in psoriatic arthritis and axial spondyloarthritis: a quasi-experimental study 2025 ·RMD Open ·(unknown),Johanna E Vriezekolk,Nathan den Broeder,(unknown),Alfons A den Broeder,Noortje van Herwaarden,E. Mahler,Emmerik F A Leijten	0
2	Similar gout flare incidence rates when using once- or twice-daily 0.5 mg colchicine prophylaxis after the start of xanthine oxidase inhibitors 2025 ·Scandinavian Journal of Rheumatology ·(unknown),(unknown),Lise M Verhoef,Alfons A den Broeder,Wing‐Yee Kwok,Noortje van Herwaarden,Marcel Flendrie	0
3	Adalimumab serum concentration to choose a subsequent biological DMARD in patients with rheumatoid arthritis (ADDORA-switch): results of a blinded randomised test-treatment trial 2025 ·Annals of the Rheumatic Diseases ·(unknown),(unknown),Gertjan Wolbink,Michael T. Nurmohamed,Maarten Boers,Femke Hooijberg,Theo Rispens,Annick de Vries,Ronald van Vollenhoven,Sofía Ramiro,Noortje van Herwaarden,Bart J. F. van den Bemt,Alfons A den Broeder	0
4	Long-Term Routine Laboratory Toxicity Monitoring of Immunomodulatory Drugs in Rheumatoid Arthritis 2025 ·Annals of Internal Medicine ·(unknown),Nathan den Broeder,(unknown),(unknown),(unknown),(unknown),Robert Landewé,Noortje van Herwaarden,Alfons A den Broeder	0
5	Effectiveness of treat-to-target tapering of TNF inhibitors for psoriatic arthritis and axial spondyloarthritis in the Netherlands: 24-month follow-up of the DRESS-PS trial 2025 ·The Lancet Rheumatology ·André Peeters,(unknown),E. Mahler,Lise M Verhoef,Alfons A den Broeder,Nathan den Broeder,Noortje van Herwaarden	0
6	Ischaemic cardiovascular risk with allopurinol and protective effect of colchicine in gout: a Dutch nationwide pharmaco-epidemiological study 2025 ·European Journal of Preventive Cardiology ·(unknown),(unknown),Isla S. Mackenzie,(unknown),Marcel Flendrie,Călin D. Popa,(unknown),Dina Vojinović,Leo A. B. Joosten,Bas Schouwenberg,Martijn Gerritsen,Alfons A den Broeder,Noortje van Herwaarden	0
7	Construct validity of Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) and Ankylosing Spondylitis Disease Activity Score (ASDAS) treatment target cut-offs in a BASDAI treat-to-target axial spondyloarthritis cohort: a cross-sectional study 2023 ·Scandinavian Journal of Rheumatology ·(unknown),(unknown),F. van Gaalen,(unknown),(unknown),Nathan den Broeder,Alfons A den Broeder	6
8	Serum drug levels and anti-drug antibodies in the context of dose tapering by interval prolongation of adalimumab, etanercept and ustekinumab in psoriasis patients: results of the CONDOR trial 2022 ·Journal of Dermatological Treatment ·(unknown),Sophie E. Berends,Hans Groenewoud,Ron A. A. Mathôt,(unknown),J.M. Mommers,Paul M. Ossenkoppele,M.I.A. Koetsier,M.A.M. Berends,Annick de Vries,P.C.M. van de Kerkhof,Alfons A den Broeder,E.M.G.J. de Jong,J. M. P. A. van den Reek	8
9	Treat-to-target dose reduction and withdrawal strategy of TNF inhibitors in psoriatic arthritis and axial spondyloarthritis: a randomised controlled non-inferiority trial 2022 ·Annals of the Rheumatic Diseases ·(unknown),Nathan den Broeder,F.H.J. van den Hoogen,E. Mahler,Steven Teerenstra,Désirée van der Heijde,Lise M Verhoef,Alfons A den Broeder	21
10	Tumour necrosis factor inhibitor dose adaptation in psoriatic arthritis and axial spondyloarthritis (TAPAS): a retrospective cohort study 2021 ·Lara D. Veeken ·(unknown),Nathan den Broeder,(unknown),F.H.J. van den Hoogen,Lise M Verhoef,Alfons A den Broeder	10
11	Response To: 'Effectiveness of Low-Dose Radiation Therapy on Symptoms in Patients With Knee Osteoarthritis' 2020 ·Annals of the Rheumatic Diseases ·E. Mahler,M.J.M. Minten,(unknown),P Poortmans,J.W.H. Leer,Simone S. Boks,F.H.J. van den Hoogen,Alfons A den Broeder,C.H.M. van den Ende	1
12	Predictive value of serum calprotectin (S100A8/A9) for clinical response after starting or tapering anti-TNF treatment in patients with rheumatoid arthritis 2018 ·RMD Open ·Lieke Tweehuysen,Nathan den Broeder,Noortje van Herwaarden,Leo A. B. Joosten,P.L. van Lent,Thomas Vogl,F.H.J. van den Hoogen,Rogier M. Thurlings,Alfons A den Broeder	29
13	Rheumatologists' guideline adherence in rheumatoid arthritis: a randomised controlled study on electronic decision support, education and feedback. 2018 ·PubMed ·(unknown),Ronald van Vollenhoven,Reinier Akkermans,Lise M Verhoef,Marlies Hulscher,Alfons A den Broeder	10
14	The effects of an educational meeting and subsequent computer reminders on the ordering of laboratory tests by rheumatologists: an interrupted time series analysis. 2017 ·PubMed ·(unknown),Nathan den Broeder,(unknown),Ester Piek,Steven Teerenstra,Marlies Hulscher,Ronald van Vollenhoven,Alfons A den Broeder	2
15	Are ultrasonographic signs of inflammation predictors for response to intra-articular glucocorticoids in knee osteoarthritis? 2015 ·PubMed ·(unknown),(unknown),Johanna E Vriezekolk,J.W. Bijlsma,Alfons A den Broeder	11
16	Randomised Controlled Non-Inferiority Study of Dose Reduction and Withdrawal of Adalimumab and Etanercept in Rheumatoid Arthritis. 2014 ·Arthritis & Rheumatism ·Noortje van Herwaarden,Aatke van der Maas,M.J.M. Minten,(unknown),Ronald van Vollenhoven,(unknown),(unknown),Alfons A den Broeder	2
17	Improvement in deployment of MRI of the sacroiliac joints in patients suspected for spondyloarthritis using a targeted intervention: a case study 2013 ·Lara D. Veeken ·(unknown),Alfons A den Broeder,(unknown),Désirée van der Heijde,M. Reijnierse	5
18	Should We Redefine Treatment Targets in Rheumatoid Arthritis? Low Disease Activity Is Sufficiently Strict for Patients Who Are Anticitrullinated Protein Antibody-negative 2013 ·The Journal of Rheumatology ·(unknown),(unknown),Alfons A den Broeder,(unknown),Piet L. van Riel,Jaap Fransen	24
19	Treatment strategies aiming at remission in early rheumatoid arthritis patients: starting with methotrexate monotherapy is cost-effective 2011 ·Lara D. Veeken ·L.G. Schipper,Wietske Kievit,Alfons A den Broeder,(unknown),Eddy Adang,Jaap Fransen,Piet L. C. M. van Riel	34
20	A SINGLE DOSE PLACEBO CONTROLLED PHASE I STUDY OF THE FULLY HUMAN ANTI-TNF ANTIBODY D2E7 IN PATIENTS WITH RHEUMATOID ARTHRITIS 1998 ·Arthritis & Rheumatism ·Leo van de Putte,Piet L. C. M. van Riel,Alfons A den Broeder,Oliver Sander,Rolf Rau,Christina Binder,Klaus Krüger,M Schattenkirchner,Helmut Fenner,Jochen Salfeld,(unknown),H. Küpper,J. Kempeni	21

About Alfons A den Broeder

Alfons A den Broeder is a scholar working on Rheumatology, Hematology and Genetics, having authored 225 papers that have together received 5.0k indexed citations. Recurring topics across this work include Rheumatoid Arthritis Research and Therapies (143 papers), Autoimmune and Inflammatory Disorders Research (44 papers) and Systemic Lupus Erythematosus Research (42 papers). The work is most often cited by research in Rheumatology (3.5k citations), Hematology (966 citations) and Immunology (1.3k citations). Alfons A den Broeder has collaborated with scholars based in Netherlands, United States and United Kingdom. Frequent co-authors include F.H.J. van den Hoogen, Jaap Fransen, Piet L. C. M. van Riel, C.H.M. van den Ende, Bart J. F. van den Bemt, Aatke van der Maas, Wietske Kievit, Călin D. Popa, Noortje van Herwaarden and Elke Arts. Their work appears in journals such as Annals of Internal Medicine, PLoS ONE and Scientific Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact